AOTI, Inc. (AOTI.L) Research

AOTI, Inc. specializes in creating and marketing healthcare technologies specifically designed for treating persistent and hard-to-heal wounds. Among its offerings are the innovative Topical Wound Oxygen (TWO2) Therapy and the NEXA Negative Pressure Wound Therapy (NPWT) System. Michael Stephen Griffiths founded the company in 2006, and its main office is located in Oceanside, California.

Market snapshot

Symbol
AOTI.L
Price
$63.00
Day change
+6.78%
Market cap
$88.7M
P/E ratio
122.39x
52-week range
25-94.45
Sector
Healthcare
Industry
Medical - Specialties
Next earnings
in 3 months

Peer companies

  • Arecor Therapeutics plc (AREC.L)
  • Creo Medical Limited (CREO.L)
  • Hemogenyx Pharmaceuticals Plc (HEMO.L)
  • hVIVO plc (HVO.L)
  • Inspiration Healthcare Group plc (IHC.L)
  • Kooth plc (KOO.L)
  • Novacyt S.A. (NCYT.L)
  • Poolbeg Pharma PLC (POLB.L)

Open AOTI, Inc. (AOTI.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.